HCW Biologics is trading at $1.55, down 7.7% in pre-market on October 5, 2026; the cause remains unconfirmed. - Shares closed at $1.68 October 2, after falling each shown session from September 24 through October 2. - The company news page lists no October 5 announcement; its latest listed release, dated September 24, announced a $1.5 million private placement, which does not establish the cause. - No clear current catalyst or volume data was found; modest market losses do not clearly explain the decline.